Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
C.Q. Pharmaceutical Holding Co., Ltd. (000950.SZ)
CNY5.59
+0.20 (+3.71%)
CN SHZ Healthcare Medical - Care Facilities
Address
No 1, Datong Road 400010
Chongqing, CN
Chongqing, CN
CEO
Wei Liu
Website
cqphar.com
IPO
1999-09-16
ISIN CNE0000010K0
Description
C.Q. Pharmaceutical Holding Co., Ltd. is a pharmaceutical company primarily involved in the development, manufacturing, and distribution of medicinal products. Established in 1950, the firm has its headquarters in Chongqing, China. Its historical lineage includes Chongqing Medicines Co., Ltd., which was previously known as the Southwest Branch of China Medicine Company. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY5.59
+0.20 (+3.71%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
58M
Beta
0.30
Float Shares
589.88M
Free Float %
34.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.69% | -5.37% | -1.53% | -1.86% | +10.25% | -0.17% | +16.90% | -18.51% | +8.19% | -22.01% | +1.57% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
5.59
DCF (Unlevered)
259.13
+4,535.6%
DCF (Levered)
50.25
+798.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-12 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.70
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+2.3% Q1'26: -0.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+37.5% ★ Q1'26: +42.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-1.0% Q1'26: -16.7% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+1.7% Q1'26: +1.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+3.5% Q1'26: +2.3% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.6% ★ Q1'26: -4.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×11.64× Q1'26: 24.68× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
4.09B
est.
|
78.40B
est: 79.63B (-1.6%)
|
67.83B
est: 79.63B (-14.8%)
|
80.56B
est: 83.45B (-3.5%)
|
82.45B
est: 86.72B (-4.9%)
|
86.72B
86.72B – 86.72B
+0.0% YoY
|
94.15B
94.15B – 94.15B
+8.6% YoY
|
102.15B
102.15B – 102.15B
+8.5% YoY
|
| EBITDA |
131.81M
est.
|
2.55B
est: 2.57B (-0.6%)
|
2.83B
est: 2.57B (+10.1%)
|
1.94B
est: 2.79B (-30.4%)
|
1.91B
est: 2.90B (-34.2%)
|
2.90B
2.90B – 2.90B
+0.0% YoY
|
3.15B
3.15B – 3.15B
+8.6% YoY
|
3.41B
3.41B – 3.41B
+8.5% YoY
|
| EBIT |
119.48M
est.
|
2.31B
est: 2.33B (-0.9%)
|
2.60B
est: 2.33B (+11.5%)
|
1.70B
est: 2.49B (-31.8%)
|
1.43B
est: 2.59B (-44.7%)
|
2.59B
2.59B – 2.59B
+0.0% YoY
|
2.81B
2.81B – 2.81B
+8.6% YoY
|
3.04B
3.04B – 3.04B
+8.5% YoY
|
| Net Income |
159.18M
est.
|
624.63M
est: 707.48M (-11.7%)
|
952.28M
est: 707.48M (+34.6%)
|
282.99M
est: 738.27M (-61.7%)
|
386.72M
est: 544.92M (-29.0%)
|
580.07M
580.07M – 580.07M
+6.5% YoY
|
650.38M
650.38M – 650.38M
+12.1% YoY
|
720.70M
720.70M – 720.70M
+10.8% YoY
|
| SGA |
194.75M
est.
|
3.68B
est: 3.79B (-3.1%)
|
3.30B
est: 3.79B (-13.1%)
|
3.97B
est: 3.48B (+14.0%)
|
1.29B
est: 3.62B (-64.4%)
|
3.62B
3.62B – 3.62B
+0.0% YoY
|
3.92B
3.92B – 3.92B
+8.6% YoY
|
4.26B
4.26B – 4.26B
+8.5% YoY
|
| EPS |
0.09
est.
|
0.36
est: 0.40 (-10.0%)
|
0.55
est: 0.40 (+37.5%)
|
0.16
est: 0.42 (-61.9%)
|
0.22
est: 0.31 (-29.0%)
|
0.33
0.33 – 0.33
+6.5% YoY
|
0.37
0.37 – 0.37
+12.1% YoY
|
0.41
0.41 – 0.41
+10.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-15 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.81B
OE per share TTM
-1.60
Owner's Yield
-28.21%
Maintenance CapEx ratio
62.26%
Maint CapEx / Avg PPE
3.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 22 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.01% | 42.2K | 0.49% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 50.4K | 0.65% |
| 3 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.01% | 1.01M | 0.07% |
| 4 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 390.7K | 0.06% |
| 5 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 14.4K | 0.44% |
| 6 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 36.2K | 0.46% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 135.3K | 0.39% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 12.5K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 28.1K | 0.26% |
| 10 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.39M | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
98.7K
Shares Outstanding
1.73B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Qinghua Yang | Deputy General Manager | — | female |
| Shaohong Li | Executive Deputy GM & Director | — | male |
| Tian Qiu | Financial Director, Chief Financial Officer & Board Secretary | — | male |
| Wei Liu | GM & Director | — | male |
| Yi Yin | Accounting Supervisor | — | — |
| Yihai Chen | Deputy GM & Non-Independent Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 000950.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
